XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementMay 17 12:51 ET · Announcements

Stocks in Play: XORTX Therapeutics Inc.

Baystreet.caMay 17 11:15 ET

XORTX Therapeutics Adjusts Warrant Terms

TipRanksMay 17 07:37 ET

XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection With October 2021 US IPO

07:01 AM EDT, 05/17/2024 (MT Newswires) -- XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO

MT NewswiresMay 17 07:01 ET

XORTX Reprices Balance of Warrants Issued in Connection With October 2021 US IPO

CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing

GlobeNewswireMay 17 07:00 ET

Xortx Therapeutics Q1 Financial Snapshot

TipRanksMay 17 06:57 ET